 |
|
Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib
Joon-Il Choi, David K Imagawa, Priya Bhosale, Puneet Bhargava, Temel Tirkes, Tara E Seery, Chandana Lall
Clin Mol Hepatol. 2014;20(2):218-222. Published online 2014 Jun 30 DOI: https://doi.org/10.3350/cmh.2014.20.2.218
|
|
Citations to this article as recorded by
 Preoperative evaluation of microvascular invasion in hepatocellular carcinoma with a radiological feature-based nomogram: a bi-centre study
Yuhui Deng, Dawei Yang, Xianzheng Tan, Hui Xu, Lixue Xu, Ahong Ren, Peng Liu, Zhenghan Yang
BMC Medical Imaging.2024;[Epub] CrossRef Radiological findings in non-surgical recurrent hepatocellular carcinoma: From locoregional treatments to immunotherapy
Davide Ippolito, Cesare Maino, Marco Gatti, Paolo Marra, Riccardo Faletti, Francesco Cortese, Riccardo Inchingolo, Sandro Sironi
World Journal of Gastroenterology.2023; 29(11): 1669. CrossRef Vascular response patterns to targeted therapies in murine breast cancer models with divergent degrees of malignancy
Emily Hoffmann, Mirjam Gerwing, Tobias Krähling, Uwe Hansen, Katharina Kronenberg, Max Masthoff, Christiane Geyer, Carsten Höltke, Lydia Wachsmuth, Regina Schinner, Verena Hoerr, Walter Heindel, Uwe Karst, Michel Eisenblätter, Bastian Maus, Anne Helfen, C
Breast Cancer Research.2023;[Epub] CrossRef Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM
Maria Ingenerf, Homeira Karim, Christoph Auernhammer, Matthias Zacherl, Vera Wenter, Michael Winkelmann, Jens Ricke, Frank Berger, Christine Schmid-Tannwald
Radiology and Oncology.2023; 57(4): 436. CrossRef Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular Carcinoma
Quan Chen, Austin Z. Chen, Guorong Jia, Jindian Li, Chuansheng Zheng, Kai Chen
Hepatology Communications.2022; 6(4): 652. CrossRef Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters
Maria Ingenerf, Sophia Kiesl, Michael Winkelmann, Christoph J. Auernhammer, Johannes Rübenthaler, Freba Grawe, Matthias P. Fabritius, Jens Ricke, Christine Schmid-Tannwald
Biomedicines.2022; 10(10): 2618. CrossRef Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging Ahmed W Moawad, Janio Szklaruk, Chandana Lall, Katherine J Blair, Ahmed O Kaseb, Amita Kamath, Scott A Rohren, Khaled M Elsayes
Journal of Hepatocellular Carcinoma.2020; Volume 7: 77. CrossRef Más allá del Li-Rads: Valoración de la respuesta a la terapia sistémica del Hepatocarcinoma
Camilo Alberto Caicedo Montaño, Sergio Andrés Velásquez Castaño, Katherine Quintero Rodríguez, Daniel Upegui Jiménez
Revista Médica Sanitas.2020; 23(2): 94. CrossRef Perfusion Magnetic Resonance as a Biomarker for Sorafenib-Treated Advanced Hepatocellular Carcinoma: A Pilot Study
Marta Campos, Isabel Candelária, Nickolas Papanikolaou, Adélia Simão, Carlos Ferreira, Georgios C. Manikis, Filipe Caseiro-Alves
GE - Portuguese Journal of Gastroenterology.2019; 26(4): 260. CrossRef Multiparametric MR diffusion-weighted imaging for monitoring the ultra-early treatment effect of sorafenib in human hepatocellular carcinoma xenografts
Xin Chen, Zelan Ma, Yanqi Huang, Lan He, Cuishan Liang, Changzheng Shi, Zhongping Zhang, Changhong Liang, Zaiyi Liu
Journal of Magnetic Resonance Imaging.2017; 46(1): 248. CrossRef Advantage of Sorafenib Combined with Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma
Zhe Tang, Muxing Kang, Bo Zhang, Jianke Chen, Heqing Fang, Qin Ye, Biao Jiang, Yulian Wu
Tumori Journal.2017; 103(3): 286. CrossRef Assessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patients
Rodolfo Sacco
World Journal of Hepatology.2015; 7(1): 33. CrossRef
|